These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
940 related articles for article (PubMed ID: 25255872)
1. Resveratrol-mediated reversal of tumor multi-drug resistance. Hu Y; Li C; Li H; Li M; Shu X Curr Drug Metab; 2014; 15(7):703-10. PubMed ID: 25255872 [TBL] [Abstract][Full Text] [Related]
2. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
3. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547 [TBL] [Abstract][Full Text] [Related]
4. 9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein. Stefan K; Schmitt SM; Wiese M J Med Chem; 2017 Nov; 60(21):8758-8780. PubMed ID: 29016119 [TBL] [Abstract][Full Text] [Related]
5. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells. Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
7. Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells. Sinha BK; Perera L; Cannon RE Biomed Pharmacother; 2019 Dec; 120():109468. PubMed ID: 31605952 [TBL] [Abstract][Full Text] [Related]
8. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901 [TBL] [Abstract][Full Text] [Related]
9. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Lee CH Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411 [TBL] [Abstract][Full Text] [Related]
10. Role of ABC transporters in cancer chemotherapy. Sun YL; Patel A; Kumar P; Chen ZS Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384 [TBL] [Abstract][Full Text] [Related]
11. Lamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp., reverses BCRP mediated drug resistance in cancer cells. Huang XC; Xiao X; Zhang YK; Talele TT; Salim AA; Chen ZS; Capon RJ Mar Drugs; 2014 Jun; 12(7):3818-37. PubMed ID: 24979269 [TBL] [Abstract][Full Text] [Related]
12. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives. Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160 [TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
15. HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2). Köhler SC; Wiese M J Med Chem; 2015 May; 58(9):3910-21. PubMed ID: 25855895 [TBL] [Abstract][Full Text] [Related]
16. Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. M F Gonçalves B; S P Cardoso D; U Ferreira MJ Molecules; 2020 Jul; 25(15):. PubMed ID: 32722234 [TBL] [Abstract][Full Text] [Related]
17. ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells. Mirzaei SA; Gholamian Dehkordi N; Ghamghami M; Amiri AH; Dalir Abdolahinia E; Elahian F Toxicol Appl Pharmacol; 2017 Dec; 337():22-29. PubMed ID: 29079042 [TBL] [Abstract][Full Text] [Related]
18. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2. Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Matsson P; Pedersen JM; Norinder U; Bergström CA; Artursson P Pharm Res; 2009 Aug; 26(8):1816-31. PubMed ID: 19421845 [TBL] [Abstract][Full Text] [Related]
20. The role of ABC transporters in clinical practice. Leonard GD; Fojo T; Bates SE Oncologist; 2003; 8(5):411-24. PubMed ID: 14530494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]